Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Forcal I Investment Fund C.V. investment portfolio
Forcal I Investment Fund C.V. has made numerous investments in companies such as Verdiva Bio, Beacon Therapeutics Holdings, and Tropic Biosciences Uk within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
| Tropic Biosciences Uk Limited Tropic Biosciences UK Ltd develops agricultural biotechnology solutions, focusing on gene‑editing technologies to create improved tropical crop varieties and traits for growers in the tropics. | Healthcare & Life Sciences | Norwich | Confirmed | 2025-07-10 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (5)
Forcal I Investment Fund C.V.'s positions across portfolio companies2026
- SERIES B3 PREFERRED 0 → 3,287,455
- SERIES C PREFERRED 0 → 572,475
- SERIES A PREFERRED 3,414,634 → 6,829,268
Articles (2)
- Forbion Bioeconomy Fund I Coöperatief U.A. takes 10.6% stake in Tropic Biosciences UK, agricultural biotech firm1 Sept 2026Tropic Biosciences Uk
- Advent Life Sciences Fund III takes 3.1% of Beacon Therapeutics21 Aug 2026Beacon Therapeutics Holdings